Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MMACHC pseudogene 1 (MMACHCP1) is classified as a pseudogene, which means it is a segment of DNA that resembles the functional MMACHC gene but does not encode a functional protein. Pseudogenes typically result from gene duplication or retrotransposition events and have lost their protein-coding ability through mutation or lack regulatory elements required for expression. MMACHCP1 is located on chromosome 3 and does not play any known active biological role or therapeutic function. No evidence indicates it acts as a direct biological target or is involved in disease processes. It is not a therapeutic target, receptor, enzyme, or protein, and has no known biological function, role in disease, or drug interaction. MMACHCP1 should not be confused with the functional MMACHC gene, which is involved in vitamin B12 metabolism and cobalamin disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MMACHC pseudogene 1 (MMACHCP1).